Mesenchymal stem cells - Sources and clinical applications

Transfusion Medicine and Hemotherapy

Volumn 35, Issue 4, 2008, Pages 272-277

  Klingemann, Hans ^a,c   Matzilevich, David ^b   Marchand, James ^c  

^a Molecular Oncology Research Institute   (United States)

^b New England Cord Blood Bank   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Differentiation; Mesenchymal stem cells; MSC; Plasticity

Indexed keywords

CISPLATIN; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ADIPOSE TISSUE; ADULT; AMNION; BONE MARROW; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CROHN DISEASE; CYTOKINE PRODUCTION; ECTODERM; ENDODERM; GENE EXPRESSION; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; PLACENTA; PLASTIC SURGERY; REVIEW; SENESCENCE; TOOTH PULP; UMBILICAL CORD; UMBILICAL CORD BLOOD;

EID: 58549092785     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142333     Document Type: Review

References (40)

1. Pittinger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-47.
2. Javazon EH, Neggs KJ, Flake AW: Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004:32;414-25.
3. Da Silva ML, Chagastelles PC, Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-13
4. Horowitz E, Le Blanc K, Dominici M, et al: Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-5.
5. Wagner W, Wein F, Seckinger A, et al: Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005; 33: 1402-16
6. Friedman R, Betancur M, Tuncer H, Boissel L, Klingemann H: Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation, Biol Blood Marrow Transplant 2007:13:1477-86.
7. Nadri S, Soleimani M: Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid. Cytotherapy 2007;9:729-37.
8. De Coppi P, Bartsch G, Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotech 2007;25:100-6.
9. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K: Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004;22:649-58.
10. Secco M, Zucconi E, Vieira NM, et al: Multipotent stem cells from umbilical cord: cord is richer than blood. Stem Cells 2008;26:146-50.
11. Baksh D, Yao R, Tuan RS: Comparison of proliferative and multilineage differentiation. Potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007;25:1484-92.
12. Kern S, Eichler H, Stoeve J, Klueter H, Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-301.
13. Ichim TE, Solano F, Glenn E, et al: Stem cell therapy for autism. J Transl Med 2007;5:30-8.
14. Koblas T, Harman SM, Saudek F: The application of umbilical cord blood cells in the treatment of diabetes mellitus. Rev Diabet Stud 2005;2:228-34.
15. Samokhvalov IM, Samokhvalov NI, Nishikawa S: Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature 2007;446;1056-61.
16. Troyer DL, Weiss ML: Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2007;26:591-9, review.
17. Carlin R, Davis D, Weiss M, et al: Expression of early transcription factors Oct4, Sox2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol 2006;4:8-12.
18. Boissel, L, Tuncer H, Betancur M, Wolfberg A, Klingemann H: Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. Biol Blood Marrow Transplant, in press.
19. Closs EI, Bosse K-P, Habermeier A, Rotmann A: Structure and function of cationic amino acid transporters (CATs). J Membrane Bio 2006;213:67-77.
20. Chute JP, Muramoto GG, Whitesides J, et al: Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. PNAS 2006;103:11707-12.
21. Bonne S, Gilbert B, Hatzfeld M, Chen X, Green KJ, van Roy F: Defining desmosomal plaophilin-3 interactions. J Cell Biology 2008;161:403-16.
22. Zeeberg BR, Feng W, Wang G, et al: GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003;4:R28.
23. Karahuseyinoglu S, Cinar O, Kilic E: Biology of the stem cell in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2006;25:319-31.
24. Sarugasser R, Lickorish D, Baksh D, Hosseini MM, Davies JE: Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005;23:220-9.
25. Gronthos S, Brahim J, Li W, et al: Stem cell properties of human dental pulp stem cells. J Dent Res 2002;8:531-5.
26. Yu J, Wang Y, Deng Z, Li Y, Shi J, Jin Y: Odontogenic capability: bone marrow stromal stem cells versus dental pulp stem cells. Biol Cell 2007;8:465-74.
27. Gimble JM, Guilak F: Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003;5:362-9.
28. Keyser KA, Beagles KE, Kiem H-P: Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant 2007;16:555-62.
29. Hida N, Nishiyama N, Miyoshi S: Novel cardiac precursor-like cells from human menstrual blood derived mesenchymal cells. Stem Cells 2008 [Epub ahead of print], Doi 10,1634/stemcells.2007-0826.
30. Devine SM, Cobbs C, Jenings M, Bartholomew A, Hoffman R: Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates. Blood 2003;101:2999-3001.
31. Tang YL, Zhao Q, Quin X, et al: Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 2005;80:229-37.
32. LeBlanc K, Frassoni F, Ball L, et al: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579-86.
33. Stagg J, Pommey, S, Eliopoulos N, Galipeau J: Interferon-stimulated marrow stromal cells: a new type of non-hematopoietic antigen-presenting cell. Blood 2006;107:2570-77.
34. Alfanasyev B, Polyntsev D, Zubarovskaya L, et al: Prophylaxis and treatment of GvHD with mesenchymal stem cells in patients undergoing allo HSCT. Cytotherapy 2008;10(suppl 1):abstr 67.
35. Eliopoulos N, Zhao J, Forner K, Galipeau J: Bone-marrow derived mesenchymal stromal cells protect against cisplatin-induced acute renal failure. Cytotherapy 2008;10(suppl 1):abstr 52.
36. Luciano C, Amado LC, Saliaris AP, et al: Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. PNAS 2005;102:11474-9.
37. Francoise S, Bensidhoum M, Mouiseddine M, et al: Local radiation not only induces homing of human mesenchymal cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after radiation damage. Stem Cells 2006;24:1020-9.
38. Chapel A, Semont A, Mouiseddine M, Gourmelon P: Human mesenchymal stem cells accelerate the healing of skin and increase intestinal recovery after radiation injury. Cytotherapy 2008;10(suppl 1):abstr 35.
39. Weiss M, Medicetty S, Bledsoe AR, et al: Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006;24:781-92.
40. Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K: Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Therap 2008;83:723-30.